Endocrine Abstracts

A 38–year-old female was diagnosed with right breast cancer cT2mN0M0G3 with positive BRCA+ gene mutation. The patient was treated with neoadjuvant chemotherapy plus one dose immune checkpoint inhibitor Pembrolizumab following bilateral radical mastectomy, extirpation of the right sentinel lymph nodes and bilateral reconstruction with an implant. Approximately one month after using Pembrolizumab the patient noticed extreme fatigue, decreased blood pressure, accelerated pul...